Fasciitis, Necrotizing Clinical Trial
Official title:
Raised Serum Lactate as a Marker of Necrotizing Fasciitis; a Consecutive Prospective Review.
The investigators examined the hypothesis that serum lactate is raised in early necrotizing fasciitis to a much greater extent than in other differential diagnoses, such as severe cellulitis, and therefore provides a diagnostic indicator.
A prospective comparison of serum lactate levels at referral to the Plastic Surgery team to the 'gold standard' test of histology at initial surgical debridement, looking at 53 consecutive patients referred with suspected necrotizing fasciitis to a single surgeon at one institution between 2000 and 2010. ;
Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00261807 -
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
|
N/A |